SAWAI PHARMACEUTICAL CO LTD ORDINARY SHA (OTCMKTS:SWPIF) Sellers Declined Their Shorts By 13.68%

November 10, 2018 - By Theresa McIntyre

SAWAI PHARM CO LTD (OTCMKTS:SWPIF) Corporate Logo

SAWAI PHARMACEUTICAL CO LTD ORDINARY SHA (OTCMKTS:SWPIF) had a decrease of its shorted shares by 13.68%. FINRA announced in November SWPIF’s total 737,000 shorted shares. The 853,800 previous shares are down with 13.68%. Former SWPIF’s position will need 7370 days to restore. It has 100 average volume.

Lastly it traded at $44.15.Since November 10, 2017 it’s 0.00% up thus . The stock underperformed the S&P500 by 15.62%.

Sawai Pharmaceutical Co., Ltd. manufactures and sells, imports, and exports pharmaceutical products in Japan.The company has $ market cap. It offers prescription drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc. in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins, anti-cancer, etc.Currently it has negative earnings. The firm also provides antihyperlipidemic agents, diabetes drugs, and OTC drugs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.